Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
Become a Member | Sign in
Home>Events>This Event
  Events - December 2012

Oral Solid Dosage Manufacturing Technology (1 day)

14 Dec 2012 - 14 Dec 2012 - Window Conference Venue, 13 Windsor Street, Islington, London, N1 8QG

Bookmark and Share

Oral Solid dosage forms as Tablets and Capsules, are some of the most convenient and most used methods of drug delivery.
This 1-day interactive workshop is intended to provide an understanding of the fundamentals of Oral Solid Dosage manufacture and to highlight the dependency between the various process steps.

Some of the benefits to be derived from this workshop include:

• An understanding of the basics of the Tablet Making Process.
• An appreciation of the demands of the new production environment
• An appreciation of the individual’s role in improving quality at all process stages
• A knowledge of “how things work” and how this may help in trouble shooting & fixing problems

Course Leader:
Mike Cliff is an independent training consultant specialising in the area of oral solid dosage
manufacturing technology. Mike has been a regular presenter at courses and training events
in his 34 year association with the process industries.

Who should attend?
Pharmaceutical facility manufacturing staff and maintenance staff.
Quality Assurance staff, Regulatory staff, Engineering staff, Project Managers and
anybody else involved in operations peripheral to manufacturing who require an
understanding of the basic process operations.

Course Programme

Morning session
• Introduction
• Tablet Formulation
• Impact of Powders Characteristics on Formulation Properties
• Tablet Manufacturing Process
• Dispensing
• Granulation
• Drying
• Dry Milling (Dry Granulation)

Afternoon session
• Blending
• Tablet Compression
• Coating
• Encapsulation
• Warehousing and Quarantine

Further information
Scientific News
Structure of Primary Cannabinoid Receptor is Revealed
The findings provide key insights into how natural and synthetic cannabinoids including tetrahydrocannabinol —a primary chemical in marijuana—bind at the CB1 receptor to produce their effects.
Targeting Cannabinoid CB2 Receptors in the CNS
With endogenous cannabinoids considered as a potential target to combat CNS diseases, this article examines the role of CB2R could play in fighting some disorders.
3D-Printing in Science: Conference Co-Staged with LABVOLUTION
LABVOLUTION 2017 will have an added highlight of a simultaneous conference, "3D-Printing in Science".
Charles River Acquires Agilux
Enhances Charles River’s early-stage capabilities in bioanalytical services.
Designing Drugs with a Whole New Toolbox
Researchers develop methods to design small, targeted proteins with shapes not found in nature.
Small Molecules Lead to a Big Change in Reaction Outcomes
Scientists have changed the behaviour of a group of molecules involved in carbon-oxygen bond synthesis.
Targeting Fat to Treat Cancer
Researchers develop novel cancer treatment that halts fat synthesis in cells, stunting tumors.
Hyperstable Peptides for 'On-Demand' Drugs
These small molecules can fold into different conformations that could allow for greater flexibility in precision drug design
Drug Leads Identified to Combat Heart Disease
Using three supercomputers, researchers surveyed protein structures through accelerated molecular dynamics.
Accelerating the Path to Molecules for Medicine
Researchers convert carbon-hydrogen bonds into nitriles - converting organic molecules into components of medicines.
Scroll Up
Scroll Down

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,200+ scientific videos